A class action has been filed in the United States District Court for the Southern District of New York on behalf of all purchasers of China Shenghuo Pharmaceutical Holdings, Inc. (AMEX: KUN) common stock during the period from July 23, 2007 through and including August 20, 2008 (the "Class Period").

The complaint charges that CSP and certain of its officers and directors violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 by issuing materially false and misleading statements pertaining to CSP's business prospects and condition, and filing materially false financial statements with the SEC. On August 20, 2008, the Company announced that its previously issued financial statements for the fiscal periods ended June 30, September 30, and December 30, 2007 and fiscal quarter ended March 31, 2008, should no longer be relied upon and would be restated due to certain accounting errors, internal control issues and related matters. News that the Company's financial statements must be restated caused the Company's stock price to fall dramatically damaging investors.

If you are a current shareholder or purchased shares between July 23, 2007 through and including August 20, 2008 and would like to discuss your options of exercising your rights as a shareholder, please contact us.